Search Results

This report provides methodological information on how to obtain estimates of behavioral health outcomes for populations living on and off tribal lands and provides some initial estimates using NSDUH 2005 to 2014 data.

This report provides state and substate estimates of nonmedical use of prescription pain relievers among people aged 12 or older using combined 2012-2014 National Survey on Drug Use and Health data. Estimates are provided for the nation as a whole and for each state and substate areas. Comparisons are made...

This report uses the combined 2007 to 2012 National Surveys on Drug Use and Health (NSDUHs), the 2012 Treatment Episode Data Set (TEDS), and the 2012 National Survey of Substance Abuse Treatment Services (N-SSATS) to examine opioid use and treatment among women of childbearing age (aged 15 to 44).

This spotlight uses combined 2002 to 2012 National Survey on Drug Use and Health to examine marijuana and pain reliever use among veterans and non-veterans.

This report uses NSDUH data from 2002 to 2007 on Prescription Pain Relievers. In 2007, 2.1 percent of persons aged 12 or older (an estimated 5.2 million persons) reported using prescription pain relievers nonmedically in the past month; this rate does not differ significantly from that in 2002.

This short report uses 2011 to 2014 National Survey on Drug Use and Health (NSDUH) to assess substance initiation and substance use among part-time and full-time college students aged 18 to 22.

Describes emergency department (ED) visits involving the nonmedical use of narcotic pain relievers (opioids) using data from the Drug Abuse Warning Network (DAWN). The drugs most commonly combined with narcotic pain relievers in ED visits; trends for narcotic pain relievers (2005-2011); demographic characteristics of narcotic pain reliever-related visits in 2011...

This report uses combined 2002 to 2013 National Survey on Drug Use and Health (NSDUH) to assess the average number of full-time college students aged 18 to 22 using substances for the first time per day for the year as a whole and for each month of the year. Substances...

This report presents an evaluation of the coverage, overlap, biases, strengths, and weaknesses of three sources of data on the receipt of specialty substance use treatment: the National Survey on Drug Use and Health (NSDUH), the National Survey of Substance Abuse Treatment Services (N-SSATS), and the Treatment Episode Data Set...

This report describes the results of data collection efforts conducted by the Substance Abuse and Mental Health Services Administration (SAMHSA) and the Centers for Disease Control and Prevention (CDC) related to the behavioral health (mental health and substance use) of residents of the Gulf Coast affected by the Deepwater Horizon...

This spotlight presents 2012 National Surveys on Drug Use and Health (NSDUH) data on serious thoughts of suicide in the past year among adults aged 18 or older by whether the person with serious thoughts of suicide has also used illicit drugs in the past year.

This short report uses data on drug-related emergency department (ED) visits to examine the involvement of zolpidem in ED visits that are related to overmedication. Zolpidem is a medication used to treat insomnia. Overmedication may occur when a patient takes too much of their own medications (i.e., exceeds the prescribed...

This issue of The CBHSQ Report presents facts about substance use among young adults, including initiation, receipt of treatment, and emergency department visits for substance use \

This short report uses data on drug-related emergency department (ED) visits from the Drug Abuse Warning Network (DAWN) to examine the trends and characteristics of ED visits involving drug-related suicide attempts among ED patients aged 45-64 in 2011. The report discusses the patterns for male and female patients, the drugs...

This Drug Abuse Warning Network (DAWN) short report looks at the estimated number of emergency room visits for adverse reactions involving involving the prescription sleep qie zolpidem for 2005 through 2010. The report focuses on gender, age groups and other pharmaceuticals such as pain relievers, other anti-anxiety and insomnia medications...